Surgical operations may be hazardous on patients who are being treated with steroid hormones or who have recently received such therapy. This is a problem which is likely to occur more frequently now that cortisone and the A,-steroids, prednisone and prednisolone have been made generally available. The situation may arise in one of two ways. First, the patient may be receiving small (physiological) doses of cortisone as replacement therapy for adrenal insufficiency, due either to Addison's disease, to panhypopituitarism or to total adrenalectomy. Secondly, patients may be receiving large (pharmacological) doses of cortisone or A,-steroids for the treatment of such conditions as rheumatoid arthritis, collagen disease or ulcerative colitis. Such patients may have to undergo surgical operations on account of some incidental disease or for specific complications of steroid therapy such as perforation of a peptic ulcer. While they are receiving steroid hormones in large doses, and for some months or a year or more after steroid therapy has been discontinued, these patients are suffering from potential adrenal insufficiency due to suppression of endogenous adrenal cortical function. Careful pre-operative assessment and management of patients with actual or potential adrenal insufficiency is of vital importance. Post-operative care is but a continuation of the pre-operative regime; to postpone treatment until after the operation may be to court disaster, for it is often difficult to resuscitate the patient once profound adrenal failure has supervened. Physiological Background
The Adrenal Response to Surgical Stress. It has been known for many years that patients with adrenal insufficiency are incapable of responding adequately to surgical operations. This applies even to minor procedures such as dental ex- tractions. Thorn (Laragh and Almy, 1948; Roche et al., I950; Hardy, I955) ,. by the increase in plasma levels of 17-hydroxycorticoids (Tyler et al., I953, 1954; Sandberg et al., 1954; Franksson et al., 1954, I955; Elman et al., 1955; Hammond et al., I956; Steenburg et al., I956; Helmrich et al., 1957; Virtue et al., I957) and by the increased output of corticoids and 17-ketosteroids in the urine (Venning et Hardy, 1955; Moore et al., 1955; Hammond et al., 1956; Jepson et al., I956) . The adrenal cortical response to stress is thought to be due to stimulation of the hypothalamo-hypophyseal pathways, resulting in an increased output of corti cotrophin (ACTH) by the anterior lobe of the pituitary gland (Thorn et al., 1953) . Increased corticotrophic activity has in fact been demonstrated in the blood after operations (Taylor et Thorn et al., 1953) . The risk is probably no less in patients receiving corticotrophin (ACTH) than in those who are being treated with cortisone (Salassa et al., 1953; Hayes, 1956 ). Prolonged treatment with corticotrophin leads to degranulation and later hyaline changes in the basophil cells of the anterior pituitary lobe, similar to those induced by cortisone therapy, together with basophil stippling of the chromophobe cells (Golden et al., 1950; Bennett, 1954 (Thorn et al., 1953 Salassa et al. (1953) reported two fatal cases and Fraser et al. (1952) , Lewis et al. (1953) reported one fatal case each of post-operative shock, after total doses of 8 to I4 g. of cortisone or more over periods of four months to five years. Allanby (I957) recorded a similar case after a total dose of 56o mg. of prednisolone over a period of four weeks. Forbes (1952) for as long as two years after the withdrawal of corticotrophin or steroid hormones. Obviously the degree and duration of adrenal suppression varies tremendously from patient to patient. As judged by the fall in eosinophil count and the increase in steroid concentrations in the blood and urine in response to exogenous corticotrophin, pituitary adrenal inhibition may persist for anything from two to go days after the withdrawal of steroid therapy (Boland and Headley, 1951; McIntosh and Holmes, 1951; Ragan, I953; Thorn et al., 1953; Eik-Nes et al., 1955 Macpherson, I957). Of I4 patients with haemorrhage 13 were treated conservatively and four of these died; one patient was treated surgically but was found to have multiple erosions in the stomach and intestines and died soon after operation (Allanby, I957) . In at least six of these patients steroid therapy was continued despite the occurrence of bleeding though the doses were gradually reduced.
Judging from this analysis of the literature it would appear that surgical treatment of a perforated peptic ulcer is a relatively safe procedure in a patient receiving steroid therapy. This may be due to the-fact that the perforation has in most cases occurred within 3 to 5 weAks' treatment, which may not have been long enough to lead to profound suppression of pituitary-adrenal function.
The writer has had recent experience of perforated peptic ulcer in two patients receiving steroid therapy. One patient was a man aged 49 years with rheumatoid arthritis who had received a total of 300 mg. of hydrocortisone by intraarticular injection followed by a total of approximately i g. of prednisolone by mouth during the course of six weeks. The perforation was sutured without additional steroid cover and uneventful recovery ensued. (Engleman et al., 1953) . (Thorn et al., I953 .) The dose of cortisone should be reduced gradually by 12.5 to 25 mg. every second day during the administration of corticotrophin (Thorn et al., 1953) . The administration of corticotrophin is only an adjunct to the pre-operative preparation of the patient and is not a substitute for cortisone and hydrocortisone, which must still be given as outlined over the operative period.
The writer has had recent experience of an asthmatic patient who had been receiving prednisone in doses of 30 mg. daily for one year. Prednisone was gradually withdrawn during the next two months and was followed by corticotrophin zinc i85 units over eight days. Three weeks later the output of I7-ketostoeroids in the urine was only i mg. daily but was raised to 14.5 mg. daily by the administration of corticotrophin-zinc within 48 hours, in spite of the continued administration of 30 mg. prednisone; when the prednisone was gradually withdrawn and the corticotrophin was discontinued after a total of io days the 17-ketosteroid output in the urine fell rapidly again to between 2 and 3 mg. daily.
Thus treatment with corticotrophin does not immediately restore the suppressed adrenal cortex to normal nor is the response always permanent, and its effect must be gauged by estimation of steroids in the urine, the results of which cannot be obtained within less than 48 hours. For this reason corticotrophin must not be relied on as a sole means of pre-operative preparation, though it is undoubtedly beneficial.
The reason for giving cortisone acetate intramuscularly over the operation period is that its absorption is slow and prolonged by this route and the injection thus acts as a depot; it begins to act in 3 to 4 hours, reaches its peak effect in 8 to 12 hours and continues for 24 hours or more (Thorn et al., 1953) . For the same reason this method of administration is inadequate in itself to counter the acute stress of the actual operation; the latter must be met with an intravenous infusion of hydrocortisone which acts rapidly but ceases to be effective after about 4 hours. Cortisone acetate is absorbed more rapidly from the oral than from the intramuscular route, and exerts its maximal effect in 4 to 8 hours (Thorn et al., I953) , but its use is, ofcourse, limited to the post-operative period when the patient is able to take food and therapy bv mouth.
Intravenous Therapy. Saline solutions should be used with particular caution for the purpose of intravenous therapy since patients who have already been treated with cortisone or corticotrophin may be suffering from excessive retention of sodium and water. They may also be depleted by potassium if they have been receiving large doses of cortisone or corticotrophin over long periods. Potassium supplements may therefore be necessary.
Other Measures. The administration of corticotrophin or steroid hormones is liable to induce a negative nitrogen balance (Sprague et al., 1950; Thorn et al., 1953) . This will exaggerate the negative nitrogen balance which is liable to follow any surgical operation. The loss of nitrogen resulting from treatment with corticotrophin or cortisone can be compensated for by doubling the intake of calories and protein (Pearson et al., 1949) by the administration of 4 to 12 g. of potassium chloride daily (Kinsell et al., 1952; Whitney and Bennett, I952) and by androgen therapy. The administration of testosterone propionate 25 mg. daily by intramuscular injection has been shown to reverse the negative nitrogen balance induced by 200 mg. of cortisone daily (Sprague, 1951) . Other Post-operative Complications
Infections. Treatment with corticotrophin or steroid hormones increases the susceptibility of patients to infections. The inflammatory response may be masked even though the infection continues unabated (Thorn et al., I953) . Adrenal failure is liable to supervene unless the doses of steroids are increased (Page, 1954; Jacobs and Clifford Rose, 1955; Shaper and Dyson, 1955; Allanby, 1957) .
Antibiotic therapy is therefore desirable over the period of operation, and provided this is given in adequate doses the risk of the increased doses of steroid hormones will be met (Thorn et al., 1953) .
Delayed Healing of Wounds. This complication is not as common or as serious as was originally feared. In the early days of treatment with corticotrophin and cortisone delayed healing was reported in a few instances in biopsy wounds, incisions into abscesses and bed sores (Ragan et al., 1949; Plotz et al., 1950 a.c.; Behrman and Goodman, I950; Creditor et al., I950; Videback et al., I950; Levin et al., 1953) . Delayed healing of wounds and fractures has also been reported in numerous animal experiments but some workers have not obtained this effect. It is clear that there is considerable variation in the effects on different species and the effect is also dependent upon the dose of hormones used and upon the state of nutrition (Ragan et al., I953) . In many of the animal experiments the doses were out of all proportion to those used clinically. Ragan (1953) found that healing was delayed in open granulating wounds and in wounds with intestinal anastomoses when cortisone was given in doses of more than ioo mg. daily; on doses of less than ioo mg. daily healing was only slightly prolonged and this was overcome by leaving the sutures in place for a slightly longer period than usual. Thorn et al. (I953) state that serious interference with healing rarely occurs unless the doses of steroid are unduly high (more than I50 mg. cortisone daily) and excessively prolonged and unless the intake of protein is inadequate.
Thrombo-embolic Complications. Views as to the influence of steroid therapy on thrombo-embolism are controversial. Cosgriff et al. (1950, 195I) originally reported that the clotting time of venous blood was shortened and recorded 48 episodes of thrombosis and embolism in 700 patients treated with corticotrophin or cortisone; this was a higher incidence than would have been expected without the use of endocrine therapy. Coste et al. (195i) reported five similar cases. Subsequent workers have not confirmed these results. Fahey (1951) Allanby (I957) states that the incidence of thrombo-embolism amongst patients treated with corticotrophin and steroid hormones at Guy's Hospital ' has not appeared abnormal.' Hume and Moore (I95I) considered that thrombophlebitis was perhaps more liable to follow withdrawal of steroid therapy than it was to occur during treatment; they suggested that the general liability of surgical patients to post-operative venous thrombosis might be related to the falling off of adrenal cortical activity after the increased secretion during the operation period. Steroid therapy might therefore discourage rather than provoke thrombo-embolic complications. Indeed, striking subjective and objective improvement has been reported in patients with thrombophlebitis within 24 hours' treatment with corticotrophin or cortisone (Hume and Moore, 1951; McGraw et al., 1952; Flickinger and Henderson, 1956 (Brooke, 1956; Swinton, 1956 ), but they suggest that adrenal insufficiency due to previous steroid therapy may have played a part in the high post-operative death rate reported by Truelove and Witts.
Summary
Surgical operations are hazardous on patients who are being treated with corticotrophin (ACTH) or steroid hormones, or who have previously received such treatment. This risk applies both to patients who are taking small replacement doses of cortisone for the treatment of adrenal insufficiency due to Addison's disease, hypopituitarism or previous adrenalectomy and to patients who have been given pharmacological doses of corticotrophin or steroids for the treatment of such condition as rheumatoid arthritis, collagen diseases and ulcerative colitis. In all such patients endogenous cortical adrenal function and the capacity to respond to surgical stress are absent or impaired. Post-operative adrenal failure is liable to occur and is often fatal, unless the doses of hormone are increased over the period of the operation. The risk applies to minor as well as major operations and may still exist as long as two years after steroid therapy has been withdrawn.
Although comparatively few cases of postoperative adrenal failure have been reported after pharmacological steroid therapy, there is no reliable means of predicting which patients are likely to be susceptible. Therefore, full supportive endocrine therapy, with additional doses of intramuscular cortisone acetate and intravenous hydrocortisone, should be given over the period of the operation in all cases. In the case of elective surgery the operation should be deferred until an expert physician has been consulted and preliminary stimulation with corticotrophin has been carried out.
Patients who require operations for perforated or bleeding peptic ulcers also need additional doses of steroids, even though these complications may be the direct result of steroid therapy.
An enquiry as to present or past steroid therapy should become a routine item in the taking of case histories and every patient receiving such treatment should carry written information as to diagnosis and steroid dosage, with instructions to present this information immediately to the surgeon attending him.
Sodium retention and potassium depletion are liable to occur and the usual post-operative negative nitrogen balance is liable to be accentuated. Avoidance of excessive sodium chloride, an increased intake of calories, protein and potassium and, if necessary, the administration of testosterone, will obviate the semetabolic disturbances.
Susceptibility to infections is increased and antibiotic cover is always desirable.
Healing of wounds seldom presents any serious problem and there is little evidence of an increased tendency to thrombo-embolic complications.
